Back to ROYAL BANK OF CANADA ROYAL BANK OF CANADA

QNTMQNTM
8 quarters

Position history for ROYAL BANK OF CANADAROYAL BANK OF CANADA's holdings in QUANTUM BIOPHARMA LTD

Yes. Royal Bank of Canada holds 446 shares of QNTM (Quantum Biopharma), worth $2,000, as of its Q2 2026 13F filing. It increased the position from 19 shares in Q1 2026. Royal Bank of Canada has held QNTM since Q3 2024, across 8 quarterly 13F filings.

Current Value

$2,000

Current Shares

446

Total Value Change

+$2,000

Total Shares Change

+339

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
446
+2247.4%
$2,0000.0%$3.62
12
2026-Q1
Decreased
19
-65.5%
$00.0%$4.83
0
2025-Q4
Decreased
55
-90.6%
$00.0%$7.30
0
2025-Q3
Increased
583
+611.0%
$10,0000.0%$16.40
19
2025-Q2
Increased
82
+331.6%
$2,0000.0%$20.25
12
2025-Q1
Decreased
19
-95.0%
$00.0%$7.71
0
2024-Q4
Increased
379
+254.2%
$1,0000.0%$3.68
12
2024-Q3
New
107
-
$00.0%$4.00
17

Other major holders of QNTM: UBS Group AG, Virtu Financial LLC, LPL Financial LLC, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used